WB100

News alerts, weekly reports and conference planners

Company:

Weben Pharma

Drug class:

MYC inhibitor

Related drugs:

MYC overexpression	Gastric Cancer	MYC overexpression	Gastric Cancer	WB100 Sensitive: D – Preclinical WB100 Sensitive : D	WB100 Sensitive: D – Preclinical WB100 Sensitive : D
MYC overexpression	Pancreatic Ductal Adenocarcinoma	MYC overexpression	Pancreatic Ductal Adenocarcinoma	WB100 Sensitive: D – Preclinical WB100 Sensitive : D	WB100 Sensitive: D – Preclinical WB100 Sensitive : D
MYC overexpression	Acute Myelogenous Leukemia	MYC overexpression	Acute Myelogenous Leukemia	WB100 Sensitive: D – Preclinical WB100 Sensitive : D	WB100 Sensitive: D – Preclinical WB100 Sensitive : D

Associations
(3)